Status:
UNKNOWN
Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection.
Lead Sponsor:
Parc de Salut Mar
Conditions:
HIV -1 Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Objectives: MAIN: To evaluate the parameters of microbial translocation after treatment with probiotics (Saccharomyces boulardii) in HIV+ patients and its role on immune reconstitution and the changes...
Eligibility Criteria
Inclusion
- Patients with chronic HIV infection and viral load undetectable \> two years with stable ART CD4\> 400 cells / ml.
- Patients with chronic HIV infection and viral load undetectable\> two years with stable ART CD4 \<350 cells / ml.
- Inform consent signed.
- Aged between 18- No limit.
Exclusion
- Patients who receive or have received in the past 6 months food supplements containing probiotics.
- Patients who have received antibiotic treatment in the last two months
- Patients who are poor presupposes adherence to dietary supplements.
- Patients who have changed the TAR in the last three months.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01908049
Start Date
August 1 2012
End Date
March 1 2017
Last Update
November 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Mar
Barcelona, Barcelona, Spain, 08003